Patents by Inventor Karen R. Drexler

Karen R. Drexler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7347973
    Abstract: An analyte detection system is provided with calibration information uniquely specific to the set of test strips to which the sample is to be applied. The calibration information may be stored in permanent memory of the testing device, such that the device is discarded after use of all the test strips in a kit, or it may be stored in a calibration chip accompanying the set of test strips and distributed therewith, thereby enabling re-use of the testing device with a different set of test strips and associated calibration chip.
    Type: Grant
    Filed: April 4, 2003
    Date of Patent: March 25, 2008
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Joel S. Douglas, Karen R. Drexler, Jeffrey N. Roe
  • Publication number: 20040234415
    Abstract: An analyte detection system is provided with calibration information uniquely specific to the set of test strips to which the sample is to be applied. The calibration information may be stored in permanent memory of the testing device, such that the device is discarded after use of all the test strips in a kit, or it may be stored in a calibration chip accompanying the set of test strips and distributed therewith, thereby enabling re-use of the testing device with a different set of test strips and associated calibration chip.
    Type: Application
    Filed: April 4, 2003
    Publication date: November 25, 2004
    Inventors: Joel S. Douglas, Karen R. Drexler, Jeffrey N. Roe
  • Patent number: 6818180
    Abstract: Devices and methods for utilizing dry chemistry dye indicator systems for body fluid analysis such as glucose level in whole blood are provided by incorporating a porous membrane with a skin side which enables separation of whole blood and visually reading the indicator without removing the red blood cell portion of the blood from the membrane. The devices also enable visual reading of the indicator by use of a membrane or matrix which provides separation of whole blood in a lateral flow of the blood through the matrix from the input area to a test area of the matrix. The devices also provide for microtitration of fluid samples in fixed volumetric openings containing indicator reagent. Another aspect of the device provides a determination of hematocrit level in whole blood in combination with indicator indication of analyte concentration which can be compensated for the hematocrit level. The devices provided are low cost.
    Type: Grant
    Filed: June 14, 2001
    Date of Patent: November 16, 2004
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Joel S. Douglas, Karen R. Drexler, James N. Wilson
  • Publication number: 20030219357
    Abstract: An analyte detection system is provided with calibration information uniquely specific to the set of test strips to which the sample is to be applied. The calibration information may be stored in permanent memory of the testing device, such that the device is discarded after use of all the test strips in a kit, or it may be stored in a calibration chip accompanying the set of test strips and distributed therewith, thereby enabling re-use of the testing device with a different set of test strips and associated calibration chip.
    Type: Application
    Filed: April 4, 2003
    Publication date: November 27, 2003
    Inventors: Joel S. Douglas, Karen R. Drexler, Jeffrey N. Roe
  • Patent number: 6544475
    Abstract: An analyte detection system is provided with calibration information uniquely specific to the set of test strips to which the sample is to be applied. The calibration information may be stored in permanent memory of the testing device, such that the device is discarded after use of all the test strips in a kit, or it may be stored in a calibration chip accompanying the set of test strips and distributed therewith, thereby enabling re-use of the testing device with a different set of test strips and associated calibration chip.
    Type: Grant
    Filed: April 10, 2000
    Date of Patent: April 8, 2003
    Assignee: Amira Medical
    Inventors: Joel S. Douglas, Karen R. Drexler, Jeffrey N. Roe
  • Patent number: 6379915
    Abstract: A dry chemistry dye indicator composition provides improved shelf life, stable color indication end point and capability for a system at near normal pH. The novel dry chemistry dye indication system comprises 3-Methyl-6-(sodium sulfonate)-benzothiazolinone-(2)-hydrazone (MBTH-S). A preferred dye systems are based on the dye couple (MBTH-S) and 8-anilino-1-naphthalenesulfonate (ANS), and the dye couple MBTH-S and N-(3-sulfopropyl)analine. These dye indicator systems are used in conventional blood chemistry test strips and are particularly preferred for indication of glucose in blood.
    Type: Grant
    Filed: March 20, 2000
    Date of Patent: April 30, 2002
    Assignee: Amira Medical
    Inventors: Joel S. Douglas, Karen R. Drexler
  • Publication number: 20010039057
    Abstract: Devices and methods for utilizing dry chemistry dye indicator systems for body fluid analysis such as glucose level in whole blood are provided by incorporating a porous membrane with a skin side which enables separation of whole blood and visually reading the indicator without removing the red blood cell portion of the blood from the membrane. The devices also enable visual reading of the indicator by use of a membrane or matrix which provides separation of whole blood in a lateral flow of the blood through the matrix from the input area to a test area of the matrix . The devices also provide for microtitration of fluid samples in fixed volumetric openings containing indicator reagent. Another aspect of the device provides a determination of hematocrit level in whole blood in combination with indicator indication of analyte concentration which can be compensated for the hematocrit level. The devices provided are low cost due to efficient manufacturing methods provided.
    Type: Application
    Filed: June 14, 2001
    Publication date: November 8, 2001
    Inventors: Joel S. Douglas, Karen R. Drexler, James N. Wilson
  • Patent number: 6242207
    Abstract: A dry chemistry reagent matrix composition is provided containing a matrix material and a reagent composition containing 3-methyl-6(sulfonate salt)-benzothiazolinone-(2)-hydrazone (MBTH-S), N-ethyl-N-(3-sulfopropyl)aniline, and an oxidase enzyme or a peroxidase enzyme or a mixture thereof. The dry chemistry reagent matrix composition is useful in reagent test strips for determining the presence or concentration of an analyte in a fluid sample, such as blood.
    Type: Grant
    Filed: October 4, 1999
    Date of Patent: June 5, 2001
    Assignee: Amira Medical
    Inventors: Joel S. Douglas, Karen R. Drexler, John M. Gleisner, John H. Priest
  • Patent number: 6106780
    Abstract: An analyte detection system is provided with calibration information uniquely specific to the set of test strips to which the sample is to be applied. The calibration information may be stored in permanent memory of the testing device, such that the device is discarded after use of all the test strips in a kit, or it may be stored in a calibration chip accompanying the set of test strips and distributed therewith, thereby enabling re-use of the testing device with a different set of test strips and associated calibration chip.
    Type: Grant
    Filed: January 11, 1999
    Date of Patent: August 22, 2000
    Assignee: Amira Medical
    Inventors: Joel S. Douglas, Karen R. Drexler, Jeffrey N. Roe
  • Patent number: 6040151
    Abstract: A dry chemistry dye indicator composition provides improved shelf life, stable color indication end point and capability for a system at near normal pH. The novel dry chemistry dye indication system comprises 3-Methyl-6-(sodium sulfonate)-benzothiazolinone-(2)-hydrazone (MBTH-S). A preferred dye systems are based on the dye couple (MBTH-S) and 8-anilino-1-naphthalenesulfonate (ANS), and the dye couple MBTH-S and N-(3-sulfopropyl)analine. These dye indicator systems are used in conventional blood chemistry test strips and are particularly preferred for indication of glucose in blood.
    Type: Grant
    Filed: March 22, 1999
    Date of Patent: March 21, 2000
    Assignee: Mercury Diagnostics, Inc.
    Inventors: Joel S. Douglas, Karen R. Drexler
  • Patent number: 5989845
    Abstract: A dry chemistry reagent matrix composition is provided containing a matrix material and a reagent composition containing 3-methyl-6-(sulfonate salt)-benzothiazolinone-(2)-hydrazone (MBTH-S), N-ethyl-N-(3-sulfopropyl)aniline, and an oxidase enzyme or a peroxidase enzyme or a mixture thereof. The dry chemistry reagent matrix composition is useful in reagent test strips for determining the presence or concentration of an analyte in a fluid sample, such as blood.
    Type: Grant
    Filed: September 10, 1998
    Date of Patent: November 23, 1999
    Assignee: Mercury Diagnostics, Inc.
    Inventors: Joel S. Douglas, Karen R. Drexler
  • Patent number: 5962215
    Abstract: Devices and methods for utilizing dry chemistry dye indicator systems for body fluid analysis such as glucose level in whole blood are provided by incorporating a porous membrane with a skin side which enables separation of whole blood and visually reading the indicator without removing the red blood cell portion of the blood from the membrane. The devices also enable visual reading of the indicator by use of a cellulose fiber glass composite matrix which provides separation of whole blood in a lateral flow of the blood through the matrix from the input area to a test area of the matrix. Another aspect of the device provides a determination of hematocrit level in whole blood by measuring flow rate through a restricted passageway in the device.
    Type: Grant
    Filed: April 5, 1996
    Date of Patent: October 5, 1999
    Assignee: Mercury Diagnostics, Inc.
    Inventors: Joel S. Douglas, Karen R. Drexler, James N. Wilson
  • Patent number: 5885790
    Abstract: A dry chemistry dye indicator composition provides improved shelf life, stable color indication end point and capability for a system at near normal pH. The novel dry chemistry dye indication system comprises 3-Methyl-6-(sodium sulfonate)-benzothiazolinone-(2)-hydrazone (MBTH-S). A preferred dye systems are based on the dye couple (MBTH-S) and 8-anilino-1-naphthalenesulfonate (ANS), and the dye couple MBTH-S and N-(3-sulfopropyl)analine. These dye indicator systems are used in conventional blood chemistry test strips and are particularly preferred for indication of glucose in blood.
    Type: Grant
    Filed: March 10, 1998
    Date of Patent: March 23, 1999
    Assignee: Mercury Diagnostics, Inc.
    Inventors: Joel S. Douglas, Karen R. Drexler
  • Patent number: 5872713
    Abstract: An analyte detection system is provided with calibration information uniquely specific to the set of test strips to which the sample is to be applied. The calibration information may be stored in permanent memory of the testing device, such that the device is discarded after use of all the test strips in a kit, or it may be stored in a calibration chip accompanying the set of test strips and distributed therewith, thereby enabling re-use of the testing device with a different set of test strips and associated calibration chip.
    Type: Grant
    Filed: October 30, 1997
    Date of Patent: February 16, 1999
    Assignee: Mercury Diagnostics, Inc.
    Inventors: Joel S. Douglas, Karen R. Drexler, Jeffrey N. Roe
  • Patent number: 5776719
    Abstract: A dry chemistry dye indicator composition provides improved shelf life, stable color indication end point and capability for a system at near normal pH. The novel dry chemistry dye indication system comprises 3-Methyl-6-(sodium sulfonate)-benzothiazolinone-(2)-hydrazone (MBTH-S). A preferred dye systems are based on the dye couple (MBTH-S) and 8-anilino-1-naphthalenesulfonate (ANS), and the dye couple MBTH-S and N-(3-sulfopropyl)analine. These dye indicator systems are used in conventional blood chemistry test strips and are particularly preferred for indication of glucose in blood.
    Type: Grant
    Filed: April 5, 1996
    Date of Patent: July 7, 1998
    Assignee: Mercury Diagnostics, Inc.
    Inventors: Joel S. Douglas, Karen R. Drexler
  • Patent number: D381591
    Type: Grant
    Filed: May 31, 1996
    Date of Patent: July 29, 1997
    Assignee: LifeScan, Inc.
    Inventors: Edward G. Rice, Ernest J. Kiser, Karen R. Drexler, Jennifer Hahamian, Joel S. Douglas, Victoria Page
  • Patent number: D392391
    Type: Grant
    Filed: February 23, 1996
    Date of Patent: March 17, 1998
    Assignee: Mercury Diagnostics Inc.
    Inventors: Joel S. Douglas, Karen R. Drexler